{
  "meta": {
    "id": "test37",
    "title": "Drugs Affecting RAAS Pathway",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Perindopril acts by inhibiting:",
      "options": [
        {
          "label": "A",
          "text": "ACE",
          "correct": true
        },
        {
          "label": "B",
          "text": "Neprilysin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Both ACE and Neprilysin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Angiotensin II receptor",
          "correct": false
        }
      ],
      "correct_answer": "A. ACE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>ACE</p>\n<p><strong>Highyeild:</strong></p><p>Perindopril: Perindopril acts by competitively inhibiting ACE Sacubitril blocks Neprilysin Both ACE and neprilysin are inhibited by samapatrilat and omapatrilat Drugs like Losartan block Angiotensin II receptor Long-acting ACE inhibitor with a slow onset of action: Less chance of first dose hypotension. Though 66\u201395% of orally administered perindopril is absorbed, only about 20% is converted to the active metabolite perindoprilat</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Neprilysin inhibitor is sacubitril Option: C. Omapatrilat Dual inhibitor of ACE and neprilysin Option: D. ang ii receptor blocker is losartan.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b89dd622",
      "audio": ""
    },
    {
      "text": "Which of the following ACE inhibitor is NOT a prodrug?",
      "options": [
        {
          "label": "A",
          "text": "Fosinopril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Enalapril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ramipril",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lisinopril",
          "correct": true
        }
      ],
      "correct_answer": "D. Lisinopril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Lisinopril</p>\n<p><strong>Highyeild:</strong></p><p>Captopril and lisinopril are active rest all other ACE inhibitor are prodrugs Fosinopril\u2026\u2026. Fosinoprilat Enalapril\u2026\u2026. Enalaprilat Ramipril\u2026.. Ramiprilat Lisinopril It is the lysine derivative of enalaprilat; does not require hydrolysis to become active ACE inhibitor. Its oral absorption is slow (making first dose hypotension less likely) and incomplete, but unaffected by food. The duration of action is considerably longer, permitting single daily dose and ensuring uniform hypotensive action round the clock.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Fosinopril belongs to a group of medicines known as ACE inhibitors. It is widely used to treat high blood pressure and heart failure and may be prescribed after a heart attack. It also lowers the chances of having a heart attack or stroke. Option: B. Enalapril belongs to a group of medicines known as ACE inhibitors. It is widely used to treat high blood pressure and heart failure and may be prescribed after a heart attack. It also lowers the chances of having a heart attack or stroke. Option: C. Ramipril is widely used to treat high blood pressure and heart failure and may even be prescribed after a heart attack. It also lowers the chances of having a heart attack or stroke.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "49de1c98",
      "audio": ""
    },
    {
      "text": "The following are the advantages of Enalapril over captopril except:",
      "options": [
        {
          "label": "A",
          "text": "Longer half life",
          "correct": false
        },
        {
          "label": "B",
          "text": "Absorption not affected by food",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rash and loss of taste are less frequent",
          "correct": false
        },
        {
          "label": "D",
          "text": "Faster onset of action",
          "correct": true
        }
      ],
      "correct_answer": "D. Faster onset of action",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Faster onset of action</p>\n<p><strong>Highyeild:</strong></p><p>Advantages of Enalapril over captopril: More potent Longer half life \u2013 OD (5-20 mg OD) Absorption not affected by food Rash and loss of taste are less frequent Onset of action is slower (due to need for conversion to active metabolite), less liable to cause abrupt first dose hypotension Less side effects</p>\n<p><strong>Random:</strong></p><p>Explanation for other options: - Option:A. Longer half life Option:B. Absorption not affected by food Option:C. Rash and loss of taste are less frequent note :a,b,c are true statement</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3eef9439",
      "audio": ""
    },
    {
      "text": "Following are uses of ACE inhibitors except:",
      "options": [
        {
          "label": "A",
          "text": "Hypertension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Congestive Heart Failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diabetic Neuropathy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Scleroderma crisis",
          "correct": false
        }
      ],
      "correct_answer": "C. Diabetic Neuropathy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Diabetic Neuropathy Advantages of Enalapril over captopril: More potent Longer half life \u2013 OD (5-20 mg OD) Absorption not affected by food Rash and loss of taste are less frequent Onset of action is slower (due to need for conversion to active metabolite), less liable to cause abrupt first dose hypotension Less side effects</p>\n<p><strong>Highyeild:</strong></p><p>Therapeutic uses of ACE inhibitors Hypertension Congestive Heart Failure Myocardial Infarction Prophylaxis of high CVS risk subjects Diabetic Nephropathy Diabetic retinopathy in Type 1 diabetes Scleroderma crisis</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Congestive Heart Failure also known as congestive heart failure (CHF), is a syndrome, a group of signs and symptoms, caused by an impairment of the heart 's blood pumping function. Symptoms typically include shortness of breath, excessive fatigue, and leg swelling Option: D. Scleroderma crisis is a group of autoimmune diseases that may result in changes to the skin, blood vessels, muscles, and internal organs. The disease can be either localized to the skin or involve other organs, as well. Symptoms may include areas of thickened skin, stiffness, feeling tired, and poor blood flow</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ac6267f4",
      "audio": ""
    },
    {
      "text": "Following are advantages of ACE inhibitors compared to other antihypertensive in Chronic CHF except?",
      "options": [
        {
          "label": "A",
          "text": "Retarding/prevent ventricular hypertrophy, myocardial cell apoptosis and fibrosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Increase cardiac remodeling",
          "correct": true
        },
        {
          "label": "C",
          "text": "By inhibiting ACE, they rise kinin levels which increase cardioprotective NO and pgs",
          "correct": false
        },
        {
          "label": "D",
          "text": "Symptomatic and prognostic benefits are well established with ACE inhibitors",
          "correct": false
        }
      ],
      "correct_answer": "B. Increase cardiac remodeling",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Increase cardiac remodeling</p>\n<p><strong>Highyeild:</strong></p><p>The advantages of ACE inhibitors compared to other antihypertensives in CCF are as follows: RAS activation is important for development of symptoms and disease progression ACE inhibitors afford symptomatic as well disease modifying benefits by Causing vasodilation Retarding/preventing ventricular hypertrophy, myocardial cell apoptosis and fibrosis Retarding/preventing cardiac remodeling By inhibiting ACE they rise kinin levels which increase cardioprotective NO and pgs Symptomatic and prognostic benefits are well established So ACE inhibitors preferred almost all grades of CCF Symptomatic and prognostic benefits are well established So ACE inhibitors preferred almost all grades of CCF</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Retarding/prevent ventricular hypertrophy, myocardial cell apoptosis and fibrosis Option: C. By inhibiting ACE, they rise kinin levels which increase cardioprotective NO and pgs Option: D. Symptomatic and prognostic benefits are well established with ACE inhibitors note : a,c,d are true statement.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "89824be3",
      "audio": ""
    },
    {
      "text": "Which of the following antihypertensive drug reduces proteinuria in a diabetic patient?",
      "options": [
        {
          "label": "A",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perindopril",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chlorothiazide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clonidine",
          "correct": false
        }
      ],
      "correct_answer": "B. Perindopril",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Perindopril</p>\n<p><strong>Highyeild:</strong></p><p>ACE inhibitors like Perindopril reduces proteinuria in a diabetic patient, so ACE inhibitors are preferred in diabetic hypertensives Prolonged ACE inhibi\u00ac\u00actor therapy has been found to prevent or delay end-stage renal disease in type I as well as type II diabetics. Albuminuria (an index of glomerulopathy) remains stable in those treated with ACE inhibitor, but aggravates in untreated diabetics. Treated patients have higher creatinine clearance, require less dialysis and have longer life expectancy. Benefits appear to be due to haemodynamic (systemic and intrarenal) as well as abnormal mesangial cell growth attenuating effects of ACE inhibitors. They reduce intraglomerular pressure and hyperfiltration.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A,C,D .Are not known to reduce proteinuria in a diabetic patient.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0ca20357",
      "audio": ""
    },
    {
      "text": "Cough and angioedema in a patient receiving ACE inhibitors is due to:",
      "options": [
        {
          "label": "A",
          "text": "Bradykinin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Renin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Angiotensin-II",
          "correct": false
        },
        {
          "label": "D",
          "text": "All",
          "correct": false
        }
      ],
      "correct_answer": "A. Bradykinin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Bradykinin</p>\n<p><strong>Highyeild:</strong></p><p>Cough and angioedema in a patient receving ACE inhibitors is due to Bradykinin. Bradykinin is broken down by enzyme ACE. So, inhibition of ACE leads to high levels of Bradykinin leading to Cough and angioedema A persistent brassy cough occurs in 10\u201316% patients within 1\u20138 weeks, often requires discontinuation of the drug\u2014subsides 4\u20136 days thereafter. It is not dose related and appears to be caused by inhibition of bradykinin/substance P breakdown in the lungs of susceptible individuals.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e544e73b",
      "audio": ""
    },
    {
      "text": "56-year-old patient with essential hypertension on ACE inhibitors for 6 months develops chronic refractory dry cough. What would be the correct action to be taken?",
      "options": [
        {
          "label": "A",
          "text": "Reduce the dose of ACE inhibitor",
          "correct": false
        },
        {
          "label": "B",
          "text": "To add anti-tussives",
          "correct": false
        },
        {
          "label": "C",
          "text": "Change to Angiotensin receptor blocker (ARB)",
          "correct": true
        },
        {
          "label": "D",
          "text": "Order for a CT scan of chest",
          "correct": false
        }
      ],
      "correct_answer": "C. Change to Angiotensin receptor blocker (ARB)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Change to Angiotensin receptor blocker (ARB)</p>\n<p><strong>Highyeild:</strong></p><p>Reduce the dose of ACE inhibitor: Reducing the dose will not help as the patient is already sensitized to the adverse effects To add anti-tussives: Adding anti tussives will not help, as the cause for cough is ACE inhibitors Change to Angiotensin receptor blocker (ARB) The best next option is to shift to ARB for hypertension control. Arbs are not known to cause dry cough, as they will not inhibit degradation of bradykinin, substance P, and/or prostaglandins. Order for a CT scan of chest Ordering a CT chest is not helpful as the cause of cough is known and it burdens the patient with additional cost</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "595d8b2f",
      "audio": ""
    },
    {
      "text": "Which of the following can be combined with Enalapril without much drug interaction?",
      "options": [
        {
          "label": "A",
          "text": "Spironolactone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nsaids",
          "correct": false
        },
        {
          "label": "C",
          "text": "Amlodipine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sacubitril",
          "correct": false
        }
      ],
      "correct_answer": "C. Amlodipine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Amlodipine ACE inhibitor and Amlodipine combination is used for Hypertension management</p>\n<p><strong>Highyeild:</strong></p><p>Spironolactone and ACE inhibitors should not combine together as they both cause hyperkalemia Nsaids retain sodium and water and blunt antihypertensive effect of ACE inhibitors Sacubitril and ACE inhibitors both cause angioedema</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "078b1ac5",
      "audio": ""
    },
    {
      "text": "A patient with gout needs to be started on an ARB, which one of them is best to this patient?",
      "options": [
        {
          "label": "A",
          "text": "Telmisartan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Olmesartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Losartan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Irbesartan",
          "correct": false
        }
      ],
      "correct_answer": "C. Losartan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Losartan Angiotensin Receptor blocker which lowers uric acid levels is Losartan Losartan has mild probenecid like uricosuric action so, may be preferred in patient with gout and HTN</p>\n<p><strong>Highyeild:</strong></p><p>Losartan causes fall in BP in hypertensive patients which lasts for 24 hours, while HR remains unchanged and cardiovascular reflexes are not interfered. No significant effect on plasma lipid profile, carbohydrate tolerance or insulin sensitivity has been noted. A mild probenecid-like uricosuric action is produced.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A,B,D. These drugs do not have additional uricosuric action hence not useful in this patient with gout and htn.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2de2f06d",
      "audio": ""
    },
    {
      "text": "Angiotensin receptor blocker which blocks thromboxane A2:",
      "options": [
        {
          "label": "A",
          "text": "Losartan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Telmisartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Candesartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Olmesetran",
          "correct": false
        }
      ],
      "correct_answer": "A. Losartan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Losartan</p>\n<p><strong>Highyeild:</strong></p><p>Competitive antagonist of the thromboxane A2 receptor and attenuates platelet aggregation A metabolite of losartan reduces COX-2 mrna upregulation and COX- dependent prostaglandin generation It is a competitive antagonist and inverse agonist, 10,000 times more selective for AT1 than for AT2 receptor; does not block any other receptor or ion channel, except thromboxane A2 receptor (has some platelet antiaggregatory property). All overt actions of Ang II, viz. Vasoconstriction, central and peripheral sympathetic stimulation, release of aldosterone and Adr from adrenals, renal actions promoting salt and water reabsorption, central actions like thirst, vasopressin release and growth-promoting actions on heart and blood vessels are blocked.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B . Telmisartan is a medicine used to treat high blood pressure and heart disease. Lowering blood pressure helps to prevent future heart attack and stroke. This medicine is also effective in preserving kidney function in patients with diabetes. Option: C . Candesartan is a medicine used to treat high blood pressure and heart disease. Lowering blood pressure helps to prevent future heart attack and stroke. This medicine is also effective in preserving kidney function in patients with diabetes. Option: D. Olmesetran is a medication used to treat high blood pressure (hypertension). It is taken by mouth. Versions are available as the combination olmesartan/hydrochlorothiazide and olmesartan/amlodipine. Common side effects include dizziness</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8b38572",
      "audio": ""
    },
    {
      "text": "ARB with long half-life among the following is:",
      "options": [
        {
          "label": "A",
          "text": "Telmisartan",
          "correct": true
        },
        {
          "label": "B",
          "text": "Valsartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Olmesartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Losartan",
          "correct": false
        }
      ],
      "correct_answer": "A. Telmisartan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Telmisartan Telmisartan has long half-life of 24hrs</p>\n<p><strong>Highyeild:</strong></p><p>The AT1 receptor blocking action of telmisartan is similar to losartan, but it does not produce any active metabolite. After an oral dose, peak action occurs in 3 hours and action lasts > 24 hours. It is largely excreted unchanged in bile; dose reduction is needed in liver disease</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option B . Valsartan t1/2-6-9 hrs Option C . Olmesartan t1/2 approx 12 hr Option D . Losartan t1/2 approx 2 hr.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d6e5371",
      "audio": ""
    },
    {
      "text": "Angiotensin receptor blocker with additional Peroxisome proliferator- activated receptor gamma agonist activity is?",
      "options": [
        {
          "label": "A",
          "text": "Losartan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Candesartan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Telmisartan",
          "correct": true
        },
        {
          "label": "D",
          "text": "Eprosartan",
          "correct": false
        }
      ],
      "correct_answer": "C. Telmisartan",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Telmisartan</p>\n<p><strong>Highyeild:</strong></p><p>Two arbs, telmisartan and irbesartan, act as selective PPAR modulators Due to its partial ppar\u03b3 agonist effect, telmisartan inhibits vascular ACE activity, AT-R1 expression and increases endothelial NO synthesis preventing oxidative stress and endothelial dysfunction</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A,B,D. Do not have additional peroxisome proliferator- activated receptor gamma agonist activity.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b2d3edf9",
      "audio": ""
    }
  ]
}